QTAIM Application in Drug Development: Prediction of Relative Stability of Drug Polymorphs from Experimental Crystal Structures

被引:21
作者
Abramov, Yuriy A. [1 ]
机构
[1] Pfizer Global Res & Dev, Groton, CT USA
关键词
COMPASS FORCE-FIELD; MOLECULES; ENERGY; CRYSTALLIZATION; VALIDATION; MORPHOLOGY; RITONAVIR; PARAMETERIZATION; DERIVATION; CHEMISTRY;
D O I
10.1021/jp2039515
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Prediction of the most stable crystal form based on the strongest intermolecular hydrogen bonds (HBs) only, was successfully applied to ten polymorphic drug systems, using the Quantum Theory of Atoms in Molecules (QTAIM). The results of the predictions were demonstrated to be superior to the thermodynamic stability ranking based on molecular mechanical (COMPASS forcefield), DFT and DFT-D calculations, as well as on the QTAIM predictions based on the total intermolecular HBing interactions strength. The obtained results support the validity of the best donor/best acceptor hierarchical approach for polymorph stability analysis of drug-like molecules: weak interactions are not as important for stability ranking as the strongest HBs. In addition, the proposed QTAIM approach allowed a reasonable ranking of the relative stability of multiple polymorphic crystalline forms of two test systems, axitinib and sulfathiazole.
引用
收藏
页码:12809 / 12817
页数:9
相关论文
共 57 条
[11]   TOWARD AN ABINITIO DERIVATION OF CRYSTAL MORPHOLOGY [J].
BERKOVITCHYELLIN, Z .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (26) :8239-8253
[12]  
Bernstein J., 2020, Polymorphism in molecular crystals 2e, Vvol. 30
[13]   Crystal chemistry and solvent effects in polymorphic systems - Sulfathiazole [J].
Blagden, N ;
Davey, RJ ;
Lieberman, HF ;
Williams, L ;
Payne, R ;
Roberts, R ;
Rowe, R ;
Docherty, R .
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS, 1998, 94 (08) :1035-1044
[14]  
Brittain HG, 1999, DRUGS PHARM SCI, V95, P279
[15]   Molecular modeling of energetic materials: The parameterization and validation of nitrate esters in the COMPASS force field [J].
Bunte, SW ;
Sun, H .
JOURNAL OF PHYSICAL CHEMISTRY B, 2000, 104 (11) :2477-2489
[16]   POLYMORPHISM OF PHARMACEUTICALS AND OTHER MOLECULAR-CRYSTALS .1. THEORY OF THERMODYNAMIC RULES [J].
BURGER, A ;
RAMBERGER, R .
MIKROCHIMICA ACTA, 1979, 2 (3-4) :259-271
[17]   Development of a Targeted Polymorph Screening Approach for a Complex Polymorphic and Highly Solvating API [J].
Campeta, Anthony M. ;
Chekal, Brian P. ;
Abramov, Yuriy A. ;
Meenan, Paul A. ;
Henson, Mark J. ;
Shi, Bing ;
Singer, Robert A. ;
Horspool, Keith R. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (09) :3874-3886
[18]   The Challenges of Developing an API Crystallization Process for a Complex Polymorphic and Highly Solvating System. Part I [J].
Chekal, Brian P. ;
Campeta, Anthony M. ;
Abramov, Yuriy A. ;
Feeder, Neil ;
Glynn, Paul P. ;
McLaughlin, Robert W. ;
Meenan, Paul A. ;
Singer, Robert A. .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (06) :1327-1337
[19]   Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development [J].
Chemburkar, SR ;
Bauer, J ;
Deming, K ;
Spiwek, H ;
Patel, K ;
Morris, J ;
Henry, R ;
Spanton, S ;
Dziki, W ;
Porter, W ;
Quick, J ;
Bauer, P ;
Donaubauer, J ;
Narayanan, BA ;
Soldani, M ;
Riley, D ;
McFarland, K .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) :413-417
[20]   B3LYP augmented with an empirical dispersion term (B3LYP-D*) as applied to molecular crystals [J].
Civalleri, Bartolomeo ;
Zicovich-Wilson, Claudio M. ;
Valenzano, Loredana ;
Ugliengo, Piero .
CRYSTENGCOMM, 2008, 10 (04) :405-410